Matthew Sorenson
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Matthew Sorenson, PhD, APN, ANP-C, Director at School of Nursing, Associate Professor in Nursing, and a Consultant for the Myalgic Encephalomyelitis & Chronic Fatigue Syndrome Research Team at the Center for Community Research, College of Science and Health, DePaul University, Chicago, Illinois, US. His research interests include immunological changes in individuals with multiple sclerosis and chronic fatigue illnesses.[1][2]
Book chapter[edit | edit source]
- 2013, The implications of sensitization and kindling for chronic fatigue syndrome[3]
Notable studies[edit | edit source]
- 2007, Baseline Cortisol Levels Predict Treatment Outcomes in Chronic Fatigue Syndrome Nonpharmacologic Clinical Trial[4] (Abstract)
- 2008, Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS)[5] (Full Text)
- 2009, Kindling and oxidative stress as contributors to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[6] (Full Text)
- 2010, Possible Genetic Dysregulation in Pediatric CFS[7] (Full Text)
- 2010, A Comparison of Immune Functionality in Viral versus Non-Viral CFS Subtypes[8] (Full Text)
- 2011, An Etiological Model for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[9] (Full Text)
- 2012, The Production of Interleukin-8 Is Increased in Plasma and Peripheral Blood Mononuclear Cells of Patients with Fatigue[10] (Full Text)
- 2013, The implications of sensitization and kindling for chronic fatigue syndrome[11] (Abstract with full text available upon request)
- 2014, Brain Derived Neurotrophic Factor is Decreased in Chronic Fatigue Syndrome and Multiple Sclerosis[12] (Full Text)
- 2015, Novel Associations of F2-Isoprostanes, F3- Isoprostanes and Isofurans in Older Adults with Chronic Fatigue Syndrome: An Exploratory Study[13] (Full Text)
- 2017, Differentiating Multiple Sclerosis from Myalgic Encephalomyelitis and Chronic Fatigue Syndrome[14] (Full Text)
- 2017, Dysregulation of cytokine pathways in chronic fatigue syndrome and multiple sclerosis[15] (Abstract) (Corrigendum)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
- PubMed
- ResearchGate
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ https://csh.depaul.edu/faculty-staff/faculty-a-z/Pages/nursing/matthew-sorenson.aspx
- ↑ https://csh.depaul.edu/about/centers-and-institutes/ccr/myalgic-encephalomyelitis-cfs/Pages/default.aspx
- ↑ Jason, Leonard A; Sorenson, Matthew; Evans, Meredyth; Brown, Abigail; Flores, S; Sunnquist, Madison; Schafer, C (2013), "The implications of sensitization and kindling for chronic fatigue syndrome", N. Gotsiridze-Columbus (Ed.),Encephalitis, Encephalomyelitis, Encephalopathies: Symptoms, causes and potential complications (pages 73-94), New York: Nova Science
- ↑ Jason, Leonard A.; Torres-Harding, Susan; Maher, Kevin; Reynolds, Nadia; Brown, Molly; Sorenson, Matthew; Donalek, Julie; Corradi, Karina; Fletcher, Mary Ann; Lu, Tony (2007), "Baseline Cortisol Levels Predict Treatment Outcomes in Chronic Fatigue Syndrome Nonpharmacologic Clinical Trial", Journal of Chronic Fatigue Syndrome, 14 (4): 39-59, doi:10.3109/10573320802092039
- ↑ Torres-Harding, Susan; Sorenson, Matthew; Jason, Leonard; Maher, Kevin; Fletcher, Mary Ann (2008), "Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS)", Bulletin of the IACFS/ME, 16 (3): 19–33., PMID 21234277
- ↑ Jason, L.A., Porter, N., Herrington, J., & Sorenson, M., & Kubow, S. (2009). Kindling and oxidative stress as contributors to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Journal of Behavioral and Neuroscience Research, 7, 1-17. PMCID: PMC3022475
- ↑ Jason, Leonard; Sorenson, Matthew; Porter, Nicole; Brown, Molly; Lerch, Athena; Van der Eb, Constance; Mikovits, Judy (2010), "Possible Genetic Dysregulation in Pediatric CFS", Psychology, 1 (4): 247-251, doi:10.4236/psych.2010.14033
- ↑ Porter, Nicole; Lerch, Athena; Jason, Leonard; Sorenson, Matthew; Fletcher, Mary Ann; Herrington, Joshua (2010), "A Comparison of Immune Functionality in Viral versus Non-Viral CFS Subtypes", Journal of Behavioral and Neuroscience Research, 8 (2): 1-8, PMID 24634898
- ↑ Jason, L. A., Sorenson, M., Porter, N., & Belkairous, N. (2011). An Etiological Model for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Neuroscience and Medicine, 2(1), 14–27. http://doi.org/10.4236/nm.2011.21003
- ↑ Sorenson, Matthew; Jason, Leonard; Lerch, Athena; Porter, Nicole; Peterson, Jonna; Mathews, Herbert (2012). "The Production of Interleukin-8 is Increased in Plasma and Peripheral Blood Mononuclear Cells of Patients with Fatigue". Neuroscience and Medicine. 03 (01): 47–53. doi:10.4236/nm.2012.31007. ISSN 2158-2912.
- ↑ Jason, L.A., Sorenson, M., Evans, M., Brown, A., Flores, S., Sunnquist, M., & Schafer, C. (2013). The implications of sensitization and kindling for chronic fatigue syndrome. In N. Gotsiridze-Columbus (Ed.),Encephalitis, Encephalomyelitis, Encephalopathies: Symptoms, causes and potential complications.(pp.73-94). New York: Nova Science
- ↑ Sorenson, M., Jason, L.A., Peterson, J., Herrington, J., & Mathews, H. (2014). Brain derived neurotrophic factor is decreased in Chronic Fatigue Syndrome and Multiple Sclerosis. Journal of Neurology & Neurophysiology, S12: S2-013.
- ↑ Kubow, Stan & Sorenson, Matthew & Alkazemi, Dalal & Jackson Roberts, Lyman & Naselli Adamski, Katherine & Jason, Leonard. (2015). Novel Associations of F2-Isoprostanes, F3- Isoprostanes and Isofurans in Older Adults with Chronic Fatigue Syndrome: An Exploratory Study. Clinical Research: Open Access. 1. 1-4. doi:10.16966/clroa.103
- ↑ Jason, LA; Ohanian, D; Brown, A; Sunnquist, M; McManimen, S; Klebek, L; Fox, P; Sorenson, M (2017), "Differentiating Multiple Sclerosis from Myalgic Encephalomyelitis and Chronic Fatigue Syndrome", Insights in Biomedicine, 2 (2), doi:10.21767/2572-5610.100011
- ↑ Sorenson, Matthew; Furst, Jacob; Mathews, Herbert; Jason, Leonard A. (2017), "Dysregulation of cytokine pathways in chronic fatigue syndrome and multiple sclerosis", Fatigue: Biomedicine, Health & Behavior, 5 (3): 145-158, doi:10.1080/21641846.2017.1335237